相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
Matthias Guckenberger et al.
LANCET ONCOLOGY (2020)
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
Yolande Lievens et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Stereotactic Radiation Therapy for Renal Cell Carcinoma Brain Metastases in the Tyrosine Kinase Inhibitors Era: Outcomes of 120 Patients
Guillaume Klausner et al.
CLINICAL GENITOURINARY CANCER (2019)
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
David A. Palma et al.
LANCET (2019)
Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma
Laurence Albiges et al.
EUROPEAN UROLOGY (2019)
Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies
Nicholas G. Zaorsky et al.
EUROPEAN UROLOGY ONCOLOGY (2019)
Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?
Alexander Ruhle et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2019)
Stereotactic body radiation therapy in combination with systemic therapy for metastatic renal cell carcinoma: a prospective multicentre study
Natalia Dengina et al.
ESMO OPEN (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug group
Emmanuel Meyer et al.
EUROPEAN JOURNAL OF CANCER (2018)
Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
Linda Chen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Overall survival after stereotactic radiotherapy or surgical metastasectomy in oligometastatic renal cell carcinoma patients treated at two Swedish centres 2005-2014
M. Stenman et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy
Osama Mohamad et al.
ONCOIMMUNOLOGY (2018)
Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach
Shankar Siva et al.
NATURE REVIEWS UROLOGY (2017)
Rhinovirus is associated with severe adult community-acquired pneumonia in China
Juliane Hoerner-Rieber et al.
JOURNAL OF THORACIC DISEASE (2017)
Radiotherapy for Brain Metastases From Renal Cell Carcinoma in the Targeted Therapy Era The University of Rochester Experience
James E. Bates et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2017)
Impact of metastasectomy on prognosis in patients treated with targeted therapy for metastatic renal cell carcinoma
Dalsan You et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
Spine stereotactic radiosurgery with concurrent tyrosine kinase inhibitors for metastatic renal cell carcinoma
Jacob A. Miller et al.
JOURNAL OF NEUROSURGERY-SPINE (2016)
The Significance of Metastasectomy in Patients with Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy
Xiaoteng Yu et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Targeted therapy after complete resection of metastatic lesions in metastatic renal cell carcinoma
Yong Hyun Park et al.
INTERNATIONAL JOURNAL OF UROLOGY (2015)
Local treatments for metastases of renal cell carcinoma: a systematic review
Saeed Dabestani et al.
LANCET ONCOLOGY (2014)
The Impact of Tyrosine Kinase Inhibitors on the Multimodality Treatment of Brain Metastases From Renal Cell Carcinoma
Jonathan Verma et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2013)
Prognostic Factors of Survival for Patients With Metastatic Renal Cell Carcinoma With Brain Metastases Treated With Targeted Therapy: Results From the International Metastatic Renal Cell Carcinoma Database Consortium
Michael M. Vickers et al.
CLINICAL GENITOURINARY CANCER (2013)
The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery
D. Clay Cochran et al.
JOURNAL OF NEUROSURGERY (2012)
Simultaneous anti-angiogenic therapy and single-fraction radiosurgery in clinically relevant metastases from renal cell carcinoma
Michael Staehler et al.
BJU INTERNATIONAL (2011)
Disease Flare after Tyrosine Kinase Inhibitor Discontinuation in Patients with EGFR-Mutant Lung Cancer and Acquired Resistance to Erlotinib or Gefitinib: Implications for Clinical Trial Design
Jamie E. Chaft et al.
CLINICAL CANCER RESEARCH (2011)
Metastasectomy After Targeted Therapy in Patients With Advanced Renal Cell Carcinoma
Jose A. Karam et al.
JOURNAL OF UROLOGY (2011)
Outcome Predictors of Gamma Knife Radiosurgery for Renal Cell Carcinoma Metastases
Hideyuki Kano et al.
NEUROSURGERY (2011)
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
Robert J. Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
分享论文
